Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Metab Eng ; 33: 28-40, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26556131

RESUMO

Typical renewable liquid fuel alternatives to gasoline are not entirely compatible with current infrastructure. We have engineered Escherichia coli to selectively produce alkanes found in gasoline (propane, butane, pentane, heptane, and nonane) from renewable substrates such as glucose or glycerol. Our modular pathway framework achieves carbon-chain extension by two different mechanisms. A fatty acid synthesis route is used to generate longer chains heptane and nonane, while a more energy efficient alternative, reverse-ß-oxidation, is used for synthesis of propane, butane, and pentane. We demonstrate that both upstream (thiolase) and intermediate (thioesterase) reactions can act as control points for chain-length specificity. Specific free fatty acids are subsequently converted to alkanes using a broad-specificity carboxylic acid reductase and a cyanobacterial aldehyde decarbonylase (AD). The selectivity obtained by different module pairings provides a foundation for tuning alkane product distribution for desired fuel properties. Alternate ADs that have greater activity on shorter substrates improve observed alkane titer. However, even in an engineered host strain that significantly reduces endogenous conversion of aldehyde intermediates to alcohol byproducts, AD activity is observed to be limiting for all chain lengths. Given these insights, we discuss guiding principles for pathway selection and potential opportunities for pathway improvement.


Assuntos
Alcanos/metabolismo , Proteínas de Escherichia coli/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Gasolina/microbiologia , Engenharia Metabólica/métodos , Alcanos/isolamento & purificação , Proteínas de Escherichia coli/genética , Ácidos Graxos não Esterificados/metabolismo , Proteínas Recombinantes/metabolismo
2.
Nat Commun ; 5: 5031, 2014 Sep 24.
Artigo em Inglês | MEDLINE | ID: mdl-25248664

RESUMO

Increasingly complex metabolic pathways have been engineered by modifying natural pathways and establishing de novo pathways with enzymes from a variety of organisms. Here we apply retro-biosynthetic screening to a modular pathway design to identify a redox neutral, theoretically high yielding route to a branched C6 alcohol. Enzymes capable of converting natural E. coli metabolites into 4-methyl-pentanol (4MP) via coenzyme A (CoA)-dependent chemistry were taken from nine different organisms to form a ten-step de novo pathway. Selectivity for 4MP is enhanced through the use of key enzymes acting on acyl-CoA intermediates, a carboxylic acid reductase from Nocardia iowensis and an alcohol dehydrogenase from Leifsonia sp. strain S749. One implementation of the full pathway from glucose demonstrates selective carbon chain extension and acid reduction with 4MP constituting 81% (90±7 mg l(-1)) of the observed alcohol products. The highest observed 4MP titre is 192±23 mg l(-1). These results demonstrate the ability of modular pathway screening to facilitate de novo pathway engineering.


Assuntos
Proteínas de Bactérias/metabolismo , Bioengenharia/métodos , Vias Biossintéticas/fisiologia , Pentanóis/metabolismo , Álcool Desidrogenase/metabolismo , Coenzima A/metabolismo , Estrutura Molecular , Oxirredução , Oxirredutases/metabolismo , Pentanóis/química , Especificidade da Espécie , Valina/biossíntese
3.
Nat Commun ; 4: 1414, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23361005

RESUMO

The replacement of petroleum feedstocks with biomass to produce platform chemicals requires the development of appropriate conversion technologies. 3-Hydroxy-γ-butyrolactone has been identified as one such chemical; however, there are no naturally occurring biosynthetic pathways for this molecule or its hydrolyzed form, 3,4-dihydroxybutyric acid. Here we design a novel pathway to produce various chiral 3-hydroxyacids, including 3,4-dihydroxybutyric acid, consisting of enzymes that condense two acyl-CoAs, stereospecifically reduce the resulting ß-ketone and hydrolyze the CoA thioester to release the free acid. Acetyl-CoA serves as one substrate for the condensation reaction, whereas the second is produced intracellularly by a pathway enzyme that converts exogenously supplied organic acids. Feeding of butyrate, isobutyrate and glycolate results in the production of 3-hydroxyhexanoate, 3-hydroxy-4-methylvalerate and 3,4-dihydroxybutyric acid+3-hydroxy-γ-butyrolactone, respectively, molecules with potential uses in applications from materials to medicines. We also unexpectedly observe the condensation reaction resulting in the production of the 2,3-dihydroxybutyric acid isomer, a potential value-added monomer.


Assuntos
4-Butirolactona/análogos & derivados , Vias Biossintéticas , Escherichia coli/metabolismo , Hidroxiácidos/metabolismo , 4-Butirolactona/biossíntese , Vias Biossintéticas/efeitos dos fármacos , Vias Biossintéticas/genética , Escherichia coli/efeitos dos fármacos , Escherichia coli/enzimologia , Genes Bacterianos/genética , Glucose/metabolismo , Glicolatos/metabolismo , Ácido Clorídrico/farmacologia , Hidroxiácidos/química , Isomerismo , Metabolômica , Recombinação Genética/genética , Reprodutibilidade dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA